FDA inspection
Medlife Pharmacy and Compounding: FDA inspection ending Apr 18, 2018
FDA inspection 1048680 · Irvine, CA
Key facts
| Inspection ID | 1048680 |
|---|---|
| Firm | Medlife Pharmacy and Compounding |
| FEI number | 3014332926 |
| Address | 6644 Irvine Center Dr |
| City | Irvine |
| State | CA |
| ZIP | 92618-2117 |
| Fiscal year | 2018 |
| Inspection end date | Apr 18, 2018 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 607417 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data